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January 2011256 Abstractslimbs as compared with 104 of 240 limbs (43%) and 54 of 240 limbs (23%)
in groups AbL and NL; P  .0000 and P  .003, respectively. In 4 of 23
(17%) limbs in group AbL, lymphangiography normalized after stenting.
Quality of life scores in group AbL showed significant improvement in the
work-related leg swelling category, but the other four categories were
unimproved. Quality of life scores in group NL showed significant improve-
ment in the work-related leg swelling, pain, and sleep categories and in the
cumulative score. These outcome scores were significantly greater in group
NL as compared with group AbL.
Conclusions: Clinical features and abnormal lymphangiography in
swollen limbs with chronic venous disease cannot reliably differentiate
primary from venous lymphedema. Intravascular ultrasound-guided iliac
venous stenting in limbs with abnormal lymphangiograms provides substan-
tial relief of leg swelling in almost half of the cases, but the outcome is
superior in patients with normal lymphangiograms. Despite abnormal lym-
phangiogram, it appears to be beneficial to diagnose and stent underlying
iliac vein obstruction.
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Background: The plasminogen activator system may be critical for
venous ulcer healing. Urokinase plasminogen activator receptor, which is
composed of 3 domains (DI, DII, and DIII), is expressed in the epidermal
layers of the ulcer edge. This receptor may be cleaved in the linker region
between DI and DII, yielding two separate fragments (DI and DII-III) and
exposing a highly chemotactic area on the DII-III domain that is a potent
inducer of cell migration. This study compares levels of soluble urokinase
plasminogen activator receptor (suPAR; DI-III) and its fragments in exu-
dates from healing and nonhealing venous ulcers.
Methods: Patients with venous ulcers (CEAP C6 disease) were re-
cruited from a dedicated leg ulcer clinic. Venous etiology was confirmed on
venous duplex. Ulcer exudates were aspirated from Opsite-covered ulcers at
recruitment. Acute wound exudates were collected from split skin graft
donor sites to act as controls. All exudates were centrifuged at 16,000 g for
10 minutes at 4°C and supernatants aliquoted, snap-frozen, and stored at
80°C until assayed. All patients were treated with standard compression
dressings and prospectively followed for ulcer healing, defined as complete
re-epithelialization of the ulcer within 6 months. Time-resolved fluores-
cence immunoassays were validated and used tomeasure levels of suPAR and
its fragments, DI and DII-III in wound exudates. Levels were normalized
against soluble protein concentration (mg/mL). Statistical analysis was
carried out using unpaired t test.
Results: Exudates were collected from 25 patients with venous ulcers
(13 females, 12 males; median age, 68 years; range, 34-92 years). Nine
patients were defined as healers. Control (acute) wound exudates were
obtained from seven patients (four females, three males; median age, 78
years; range, 47-88 years). Healers had significantly higher levels of DII-III
(138  19 fmol/mg) compared with non-healers (47  7 fmol/mg; P 
.0001) and controls (41  19 fmol/mg; P  .005). suPAR levels were
higher in both healers (19  5 fmol/mg) and controls (32  3 fmol/mg)
compared with non-healers (8  1 fmol/mg; P  .05 for both). There was
no significant difference in the levels of DI fragment between any of the
groups.
Conclusions: This is the first study to show that suPAR and its
fragments are present in venous ulcer exudates. Levels of suPAR and its
DII-III fragment were significantly lower in poorly healing ulcers, with the
latter providing a better discrimination between the groups. Low levels of
the nonproteolytic DII-III fragment, known to stimulate cell migration,
could be a useful predictor of ulcers that would benefit from early skin
grafting. This fragment may also represent a novel target for treatment to
promote venous ulcer healing.
Failure of Microvenous Valves in Small Superficial Veins: A Key to the
Development of Venous Ulcers
A. M. van Rij, J. Vincent, G. Hill, and G. T. Jones, The Department of
Surgery, University of Otago, Dunedin, New Zealand
Background: While some patients who develop gross varicose veins
with marked reflux fail to go on to develop the skin changes of venous
insufficiency and ulceration, other patients with similarly severe varicose
veins do develop these complications. Why this is so is not understood.
Differences in compliance in the varicose veins have been suggested. This
study using retrograde resin caste venography explores another possible
factor.
Methods: Resin castes were made of the superficial venous system in
amputated lower limbs using retrograde filling from the great saphenous
vein (GSV; similar in concept to retrograde venography to show valveincompetence in the deep venous system). Resin was injected into the GSV
at the level of the medial malleolus. Outflow vessels were ligated, directing
resin into the small superficial veins. This could only occur if valves guarding
these regions were either absent or incompetent. Following hardening of the
resin and chemical maceration of the tissues, the remaining caste was
examined with a dissectingmicroscope for the presence of valves as identified
by their unique imprint in the resin. Valves were mapped to display their (1)
competence, (2) diameter, and (3) position in the branching network
extending to the GSV.
Two groups of limbs were examined: a) those where duplex ultrasound
prior to amputation had shown no reflux in the great saphenous vein; and b)
where reflux was present along with skin changes of venous insufficiency.
Results: Variable levels of reflux were demonstrated, from the seven
limbs with normal GSV, through several generations of small veins, even out
to the small venular networks in the skin. Most of the 247 microvalves
identified were in the third generation of small veins from the GSV, and
these appeared to be most critical, as their failure most often lead to reflux
directly into the skin network. There was no such reflux seen in the leg of the
youngest subject.
In the four limbs with venous insufficiency with venous ulcer forma-
tion, there was dramatic extensive incompetence of the microvenous valves
and appearance of resin into tortuous varicose networks in the area and into
the distended capillaries.
Conclusions: Reflux and valvular incompetence occurs in the small
superficial veins of the normal lower leg in the absence of reflux in the GSV.
This may increase with age and with loss of tissue support around these small
veins. We suggest that varicose veins only go on to damage the skin when
they are associated with areas of failure of microvenous valves.
A Comparison of the Villalta and Venous Clinical Severity Scoring
Instruments in the Assessment of Post-thrombotic Syndrome
A. Jayaraj, C. Natiello, S. Nicholls, and M. Meissner, The University of
Washington, Seattle, Wash
Background: Post-thrombotic syndrome (PTS) is a common chronic
complication of acute deep venous thrombosis (DVT), with as many as
two-thirds of patients developing symptoms of pain, edema, hyperpigmen-
tation, or ulceration. There exist multiple instruments to assess PTS, includ-
ing the commonly used scoring systems put forth by Villalta et al and the
American Venous Forum’s Venous Clinical Severity Score (VCSS). At
present, studies comparing the two in their ability to identify and grade the
severity of PTS do not exist. This is important to enable comparison of
studies that have used different instruments to assess PTS. The purpose of
this study is to compare the two instruments as part of a larger randomized
controlled study that assessed the impact of graduated compressive stockings
in the prevention of PTS.
Methods: One hundred thirty-eight extremities in 69 consecutive
patients with an acute DVT documented by duplex ultrasonography were
randomized to treatment with graduated compressive stockings that pro-
vided compression of 30 to 40 mm Hg or no stockings to assess impact of
graduated compressive stockings on the prevention of PTS. As part of this
study, these patients were sequentially followed at months 1, 3, 6, 12, 18,
and 24 following diagnosis of DVT. PTS scores as defined by Villalta et al
(PTSV) and the VCSS were assessed at these follow up visits. The PTSV was
scored as absent (score 3 or 3 without objective criteria), mild to
moderate (score3 with one objective criteria), or severe (score4), while
the VCSS was assessed as absent (score 3), mild to moderate (score 4-7),
and severe (score 8), based on performance characteristics of the VCSS.
Each extremity was considered separately for analysis. The two instruments
were compared using Pearson 	2 analysis at various time points mentioned
above. Additionally, correlational statistics including Spearman correlation
and gamma statistic were computed.
Results:A significant difference was not detected in the ability of PTSV
and VCSS instruments to detect mild to moderate disease (Spearman
correlation, 0.41-0.73; gamma statistic, 0.71-0.98; P  .05). For severe
disease, the	2 test suggests a difference in the ability of the two instruments
to detect disease, although there exists good correlation (Spearman correla-
tion, 0.20-0.59; gamma statistic, 0.71-1.0; P  .05) between the two
instruments.
Conclusions: Both PTSV and the VCSS scoring systems are important
tools in the identification and follow up of PTS. There exists agreement
between the two instruments for detecting bothmild tomoderate and severe
disease.
The Need for an Intersociety Consensus Guideline for Venous Ulcer
T. F. O’Donnell Jr, The Tufts Medical Center, Boston, Mass
Background: Due to their recurrence and prolonged healing time,
venous ulcers (VU) consume considerable resources in healthcare system-
s–up to 1% of healthcare budgets in some industrialized countries. Best
practice guidelines (GLs) incorporate evidence-based diagnostic and thera-
peutic recommendations in a cost-effective manner and have been associated
